ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules A Leaver-Fay, M Tyka, SM Lewis, OF Lange, J Thompson, R Jacak, ... Methods in enzymology 487, 545-574, 2011 | 1969 | 2011 |
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA CD Richardson, GJ Ray, MA DeWitt, GL Curie, JE Corn Nature biotechnology 34 (3), 339-344, 2016 | 1219 | 2016 |
A prudent path forward for genomic engineering and germline gene modification D Baltimore, P Berg, M Botchan, D Carroll, RA Charo, G Church, JE Corn, ... Science 348 (6230), 36-38, 2015 | 935 | 2015 |
Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation MA Horlbeck, LA Gilbert, JE Villalta, B Adamson, RA Pak, Y Chen, ... elife 5, e19760, 2016 | 740 | 2016 |
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair K Lee, M Conboy, HM Park, F Jiang, HJ Kim, MA Dewitt, VA Mackley, ... Nature biomedical engineering 1 (11), 889-901, 2017 | 715 | 2017 |
Computational design of proteins targeting the conserved stem region of influenza hemagglutinin SJ Fleishman, TA Whitehead, DC Ekiert, C Dreyfus, JE Corn, EM Strauch, ... Science 332 (6031), 816-821, 2011 | 696 | 2011 |
RosettaScripts: a scripting language interface to the Rosetta macromolecular modeling suite SJ Fleishman, A Leaver-Fay, JE Corn, EM Strauch, SD Khare, N Koga, ... PloS one 6 (6), e20161, 2011 | 612 | 2011 |
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells MA DeWitt, W Magis, NL Bray, T Wang, JR Berman, F Urbinati, SJ Heo, ... Science translational medicine 8 (360), 360ra134-360ra134, 2016 | 512 | 2016 |
Cornerstones of CRISPR–Cas in drug discovery and therapy C Fellmann, BG Gowen, PC Lin, JA Doudna, JE Corn Nature reviews Drug discovery 16 (2), 89-100, 2017 | 485 | 2017 |
Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements MR Mumbach, AT Satpathy, EA Boyle, C Dai, BG Gowen, SW Cho, ... Nature genetics 49 (11), 1602-1612, 2017 | 463 | 2017 |
Advances in genome editing through control of DNA repair pathways CD Yeh, CD Richardson, JE Corn Nature cell biology 21 (12), 1468-1478, 2019 | 363 | 2019 |
Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq B Wienert, SK Wyman, CD Richardson, CD Yeh, P Akcakaya, MJ Porritt, ... Science 364 (6437), 286-289, 2019 | 360 | 2019 |
Disabling Cas9 by an anti-CRISPR DNA mimic J Shin, F Jiang, JJ Liu, NL Bray, BJ Rauch, SH Baik, E Nogales, ... Science advances 3 (7), e1701620, 2017 | 356 | 2017 |
USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria CN Cunningham, JM Baughman, L Phu, JS Tea, C Yu, M Coons, ... Nature cell biology 17 (2), 160-169, 2015 | 330 | 2015 |
Discovery of stimulation-responsive immune enhancers with CRISPR activation DR Simeonov, BG Gowen, M Boontanrart, TL Roth, JD Gagnon, ... Nature 549 (7670), 111-115, 2017 | 288 | 2017 |
SLC19A1 transports immunoreactive cyclic dinucleotides RD Luteijn, SA Zaver, BG Gowen, SK Wyman, NE Garelis, L Onia, ... Nature 573 (7774), 434-438, 2019 | 279 | 2019 |
CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway CD Richardson, KR Kazane, SJ Feng, E Zelin, NL Bray, AJ Schäfer, ... Nature genetics 50 (8), 1132-1139, 2018 | 233 | 2018 |
CRISPR germline engineering—the community speaks KS Bosley, M Botchan, AL Bredenoord, D Carroll, RA Charo, ... Nature biotechnology 33 (5), 478-486, 2015 | 213 | 2015 |
A de novo protein binding pair by computational design and directed evolution J Karanicolas, JE Corn, I Chen, LA Joachimiak, O Dym, SH Peck, ... Molecular cell 42 (2), 250-260, 2011 | 198 | 2011 |
A genome-wide ER-phagy screen highlights key roles of mitochondrial metabolism and ER-resident UFMylation JR Liang, E Lingeman, T Luong, S Ahmed, M Muhar, T Nguyen, ... Cell 180 (6), 1160-1177. e20, 2020 | 194 | 2020 |